Daisuke Takahari

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Locally Advanced

Metastatic Colorectal Cancer

Monoclonal Antibody

Top Venues

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Journal of cancer research and clinical oncology

Journal of clinical medicine

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, Shota Fukuoka, Mariko Ogura, Daisuke Takahari, Keisho Chin, Hirokazu Shoji, Natsuko Okita, Ken Kato, Naoki Ishizuka, Narikazu Boku, Kensei Yamaguchi, Eiji Shinozaki
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology 150 (7) (2024)
Izuma Nakayama, Daisuke Takahari
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative Review. Journal of clinical medicine 12 (9) (2023)
Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino, Izuma Nakayama, Shota Fukuoka, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Eiji Shinozaki
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors. BMC cancer 23 (1) (2023)
Daisuke Takahari, Izuma Nakayama
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives. International journal of clinical oncology (2023)
Izuma Nakayama, Daisuke Takahari
The Role of Angiogenesis Targeted Therapies in Metastatic Advanced Gastric Cancer: A Narrative Review. Journal of clinical medicine 12 (9) (2023)
Daisuke Takahari, Hitoshi Katai, Atsuo Takashima, Naoki Izawa, Naoki Ishizuka, Manabu Ohashi, Shinya Mikami, Takeru Wakatsuki, Izuma Nakayama, Keisho Chin, Satoshi Ida, Koshi Kumagai, Souya Nunobe, Satoru Iwasa, Hirokazu Shoji, Takeyuki Wada, Ayako Doi, Takaki Yoshikawa, Takeshi Sano, Narikazu Boku, Kensei Yamaguchi
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)
Yumiko Ota, Daisuke Takahari, Takeshi Suzuki, Hiroki Osumi, Izuma Nakayama, Akira Oki, Takeru Wakatsuki, Takashi Ichimura, Mariko Ogura, Eiji Shinozaki, Mitsukuni Suenaga, Keisho Chin, Kensei Yamaguchi
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival. Cancer chemotherapy and pharmacology 85 (2) (2020)
Daisuke Takahari, Eiji Shinozaki, Takeru Wakatsuki, Akira Ooki, Masato Ozaka, Takeshi Suzuki, Izuma Nakayama, Hiroki Osumi, Daisaku Kamiimabeppu, Taro Sato, Mariko Ogura, Mitsukuni Suenaga, Keisho Chin, Kensei Yamaguchi
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research. International journal of clinical oncology 26 (2) (2020)
Daisuke Takahari, Keisho Chin, Kensei Yamaguchi
Upcoming first-line chemotherapy for HER2-negative gastric cancer in Japan: which patients benefit from immunotherapy? Future oncology (London, England) 16 (24) (2020)
Daisuke Takahari, Keisho Chin, Naoki Ishizuka, Atsuo Takashima, Keiko Minashi, Shigenori Kadowaki, Tomohiro Nishina, Takako Eguchi Nakajima, Kenji Amagai, Nozomu Machida, Masahiro Goto, Keisei Taku, Takeru Wakatsuki, Hirokazu Shoji, Shuichi Hironaka, Narikazu Boku, Kensei Yamaguchi
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22 (6) (2019)
Daisuke Takahari, Seiji Ito, Junki Mizusawa, Hiroshi Katayama, Masanori Terashima, Mitsuru Sasako, Shinji Morita, Takashi Nomura, Makoto Yamada, Yoshiyuki Fujiwara, Yutaka Kimura, Atsuki Ikeda, Yoshio Kadokawa, Takeshi Sano, null null
Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 23 (2) (2019)
Daisuke Takahari, Junki Mizusawa, Wasaburo Koizumi, Ichinosuke Hyodo, Narikazu Boku
Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20 (5) (2017)
Sakura Iizumi, Atsuo Takashima, Yukiya Narita, Masahiro Tajika, Kei Muro, Sadayuki Kawai, Hirofumi Yasui, Tomohiro Matsushima, Daisuke Takahari, Kengo Nagashima, Narikazu Boku
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study. Cancer chemotherapy and pharmacology 80 (3) (2017)
Daisuke Takahari
Second-line chemotherapy for patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20 (3) (2017)